Anticipated correlation between lean body mass to visceral fat mass ratio and insulin resistance: NHANES 2011-2018

The relationship between body composition and insulin resistance (IR) is controversial. This study aimed to thoroughly examine the correlation between adipose tissue, lean body mass, and IR as evaluated by the Homeostatic Model Assessment (HOMA-IR).In this cross-sectional study, we utilized data from the National Health and Nutrition Examination Survey (NHANES) conducted between 2011 and 2018. Our study included 4981 subjects, and we employed multiple linear regression, smoothed curve fitting, threshold, and saturation effect analysis to investigate the relationship between lean body mass, visceral fat mass, and IR. Also, we used the lean body mass to visceral fat ratio (Log LM/VFM) as a proxy variable to analyze its association with IR alone.The study discovered a negative link between lean body mass and IR, but the visceral fat mass was positively correlated after correcting for covariates. A negative correlation was observed when the alternative variable Log LM/VFM was analyzed separately for its association with IR. This association was present regardless of whether the exposure variables were analyzed as continuous or categorical. The data analysis revealed a nonlinear relationship between Log LM/VFM and IR, as evidenced by the generalized additive model. In addition, a threshold effect with a critical value of 1.80 and a saturation effect with a critical point of 2.5 were also observed. Further subgroup analysis for sex, age, BMI, active levels, hypertension, and diabetes showed considerable robustness between the relationship of Log LM/VFM and IR.Maintaining a proper ratio of lean body mass and visceral fat is beneficial for decreasing IR.

[1]  Xia Li,et al.  Fat-to-muscle ratio is associated with insulin resistance and cardiometabolic disorders in adults with type 1 diabetes mellitus. , 2023, Diabetes, obesity & metabolism.

[2]  Lin F. Yang,et al.  Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 , 2023, The Lancet.

[3]  J. Després,et al.  BMI versus obesity subtypes in the era of precision medicine. , 2023, The lancet. Diabetes & endocrinology.

[4]  Yanting Zhou,et al.  Visceral fat correlates with insulin secretion and sensitivity independent of BMI and subcutaneous fat in Chinese with type 2 diabetes , 2023, Frontiers in Endocrinology.

[5]  Yingli Lu,et al.  Age‐specific and sex‐specific associations of visceral adipose tissue mass and fat‐to‐muscle mass ratio with risk of mortality , 2022, Journal of cachexia, sarcopenia and muscle.

[6]  Xiujun Li,et al.  Triglyceride-glucose index and the risk of heart failure: Evidence from two large cohorts and a mendelian randomization analysis , 2022, Cardiovascular Diabetology.

[7]  M. Davies,et al.  Type 2 diabetes , 2022, The Lancet.

[8]  Hanmei Xu,et al.  Trends in insulin resistance: insights into mechanisms and therapeutic strategy , 2022, Signal Transduction and Targeted Therapy.

[9]  Huilei Zhao,et al.  Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis , 2022, Cardiovascular Diabetology.

[10]  Wei Li,et al.  Association Between Fat Mass to Lean Body Mass Ratio and All-Cause Mortality Among Middle-Aged and Elderly Cancer Patients Without Obesity: A Multi-Center Observational Study in China , 2022, Frontiers in Nutrition.

[11]  Yu Xu,et al.  Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study , 2022, Diabetes care.

[12]  D. Magliano,et al.  The burden and risks of emerging complications of diabetes mellitus , 2022, Nature Reviews Endocrinology.

[13]  Wei-liang Chen,et al.  Not the enemy: superficial subcutaneous adipose tissue may bring protective benefits. , 2022, Polish archives of internal medicine.

[14]  L. Moreno,et al.  Fat-free/lean body mass in children with insulin resistance or metabolic syndrome: a systematic review and meta-analysis , 2022, BMC Pediatrics.

[15]  J. Olefsky,et al.  Inflammation in obesity, diabetes, and related disorders. , 2022, Immunity.

[16]  L. Peng,et al.  Muscle‐to‐fat ratio identifies functional impairments and cardiometabolic risk and predicts outcomes: biomarkers of sarcopenic obesity , 2021, Journal of cachexia, sarcopenia and muscle.

[17]  B. Duncan,et al.  IDF diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 , 2021, Diabetes Research and Clinical Practice.

[18]  V. Malik,et al.  An Update on the Epidemiology of Type 2 Diabetes: A Global Perspective. , 2021, Endocrinology and metabolism clinics of North America.

[19]  J. Després,et al.  Management of Obesity in Cardiovascular Practice: JACC Focus Seminar. , 2021, Journal of the American College of Cardiology.

[20]  James D. Johnson On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes , 2021, Diabetologia.

[21]  J. Sowers,et al.  Obesity, Adipose Tissue and Vascular Dysfunction. , 2021, Circulation research.

[22]  M. Buman,et al.  World Health Organization 2020 guidelines on physical activity and sedentary behaviour , 2020, British Journal of Sports Medicine.

[23]  Ji-Won Lee,et al.  Inverse association between triglyceride glucose index and muscle mass in Korean adults: 2008–2011 KNHANES , 2020, Lipids in health and disease.

[24]  S. Alkahtani,et al.  Sarcopenia Coexisting with High Adiposity Exacerbates Insulin Resistance and Dyslipidemia in Saudi Adult Men , 2020, Diabetes, metabolic syndrome and obesity : targets and therapy.

[25]  N. Stefan Causes, consequences, and treatment of metabolically unhealthy fat distribution. , 2020, The lancet. Diabetes & endocrinology.

[26]  J. Eriksson,et al.  Lean body mass is not beneficial, but may be detrimental for glucose tolerance - Splitting body mass index according to body composition. , 2020, Primary care diabetes.

[27]  C. Ballantyne,et al.  Metabolic Inflammation and Insulin Resistance in Obesity , 2020, Circulation research.

[28]  Deqiang Zheng,et al.  Relationship of obesity to adipose tissue insulin resistance , 2020, BMJ Open Diabetes Research & Care.

[29]  L. Donini,et al.  Sarcopenic obesity and insulin resistance: Application of novel body composition models. , 2020, Nutrition.

[30]  Y. Song,et al.  Fat‐to‐muscle ratio as a predictor of insulin resistance and metabolic syndrome in Korean adults , 2020, Journal of cachexia, sarcopenia and muscle.

[31]  M. Brochu,et al.  A counterintuitive perspective for the role of fat‐free mass in metabolic health , 2020, Journal of cachexia, sarcopenia and muscle.

[32]  S. Lai,et al.  Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study. , 2019, The lancet. Diabetes & endocrinology.

[33]  Hailey R Banack,et al.  Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index. , 2019, European heart journal.

[34]  L. Heilbronn,et al.  Longitudinal Changes in Insulin Resistance in Normal Weight, Overweight and Obese Individuals , 2019, Journal of clinical medicine.

[35]  S. Liatis,et al.  Obesity and cardiovascular disease: revisiting an old relationship. , 2019, Metabolism: clinical and experimental.

[36]  D. Kim,et al.  The Association of Adiponectin and Visceral Fat with Insulin Resistance and β-Cell Dysfunction , 2018, Journal of Korean medical science.

[37]  G. Shulman,et al.  Mechanisms of Insulin Action and Insulin Resistance. , 2018, Physiological reviews.

[38]  M. Brochu,et al.  Fat-free mass and glucose homeostasis: is greater fat-free mass an independent predictor of insulin resistance? , 2018, Aging Clinical and Experimental Research.

[39]  F. Blyth,et al.  Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: The Concord Health and Ageing in Men Project , 2018, Experimental Gerontology.

[40]  Y. Bao,et al.  Abdominal subcutaneous adipose tissue: a favorable adipose depot for diabetes? , 2018, Cardiovascular Diabetology.

[41]  T. Funahashi,et al.  Association of Epicardial, Visceral, and Subcutaneous Fat With Cardiometabolic Diseases. , 2017, Circulation journal : official journal of the Japanese Circulation Society.

[42]  S. Kaneko,et al.  Weight-adjusted lean body mass and calf circumference are protective against obesity-associated insulin resistance and metabolic abnormalities , 2017, Heliyon.

[43]  A. Hermann,et al.  Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls , 2016, Acta obstetricia et gynecologica Scandinavica.

[44]  M. Brochu,et al.  Association between fat free mass and glucose homeostasis: Common knowledge revisited , 2016, Ageing Research Reviews.

[45]  Y. Hwang,et al.  The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype , 2016, Cardiovascular Diabetology.

[46]  A. Greenberg,et al.  Sex differences in human adipose tissues – the biology of pear shape , 2012, Biology of Sex Differences.

[47]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[48]  D. Hu,et al.  Fasting insulin, insulin resistance and risk of hypertension in the general population: A meta-analysis. , 2017, Clinica chimica acta; international journal of clinical chemistry.